Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Completed · Phase 3

Conditions studied: Overactive Bladder, Urinary Incontinence

In brief

The purpose of this study is to assess the long term safety and effectiveness of botulinum toxin type A in treating patients with idiopathic overactive bladder with urinary incontinence.

Key facts

Study ID

NCT00915525

Run by

Allergan

People needed

829

Starts

2010-02-01

Expected to finish

2014-08-05

Last updated by the study team

2019-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participation in preceding study 191622-095 (NCT00910845) or 191622-520 (NCT00910520)

You may not qualify if…

• Females who are pregnant, nursing or planning a pregnancy
• Patient has any condition or situation which, in the Investigators opinion, would put the patient at risk from continuing treatment with botulinum toxin Type A

Where it is running

• Study site — Newport Beach, California, United States
• Study site — Ghent, Belgium
• Study site — Victoria, British Columbia, Canada
• Study site — Prague, Czechia
• Study site — Tübingen, Germany
• Study site — Warsaw, Poland
• Study site — Moscow, Russia
• Study site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.